Company Overview
Snapshot
Founded in June 2020 by Orr Inbar and Arnon Horev, QuantHealth operates with 51–200 employees. The company has raised $21.01M across 8 funding rounds from 11 investors. In October 2025, QuantHealth secured a strategic investment from Sanofi Ventures.
Business overview
QuantHealth is an AI company focused on accelerating and de-risking drug development through patient-centric drug simulations. Its AI solution enables Clinical Development and Clinical Operations teams to simulate clinical trials in numerous variations within minutes, evaluating parameters for endpoint success, commercial viability, and protocol feasibility. The in-silico platform generates synthetic evidence on therapy performance across clinical phases, supporting trial planning, indication selection, drug repurposing, and in-licensing asset evaluation. The company's Large Healthcare Model (LHM) learns deep patient-drug interactions to drive high-resolution outcome models with 86% endpoint accuracy, serving the Health Tech & Life Sciences sector.
Strategic signal
In January 2024, Accenture invested $2 million in QuantHealth, signaling strong corporate validation for its AI-powered clinical trial simulations. This investment highlights the growing industry recognition of AI's potential to transform drug development, indicating a strategic move by Accenture to leverage advanced technology in the life sciences sector and positioning QuantHealth for accelerated adoption and market expansion.
Log in to access full profile ›Company Intelligence Q&A
- What was a significant recent investment in QuantHealth?
- In October 2025, QuantHealth secured a strategic investment from Sanofi Ventures, a corporate venture capital firm, to accelerate its AI-driven clinical trials.
- When was QuantHealth's seed round announced and who were the lead investors?
- In October 2022, QuantHealth announced its seed round, which included investments from Shoni Health Ventures.
- When did QuantHealth appoint new members to its advisory board?
- In April 2024, QuantHealth appointed esteemed pharmaceutical executives to its inaugural advisory board.